The story of Viagra, and its parent company copyright, presents a intriguing case study for investors. Originally a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of lower-priced alternatives , significantly eroding its position . While certain pharmaceutical companies may seek to capitalize on similar condit